Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
Condition: Hepatitis B Virus (HBV) Interventions: Biological: ETV/TDF+T101 No.1; Biological: ETV/TDF+T101 No.2; Biological: ETV or TDF; Biological: ETV/TDF+Peg-IFNα-2b Sponsor: Tasly Tianjin Biopharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials